| __timestamp | Viking Therapeutics, Inc. | Viridian Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 22223073 | 293000 |
| Thursday, January 1, 2015 | 6966842 | 1002000 |
| Friday, January 1, 2016 | 9000499 | 888000 |
| Sunday, January 1, 2017 | 13741186 | 19623000 |
| Monday, January 1, 2018 | 19040000 | 30421000 |
| Tuesday, January 1, 2019 | 23559000 | 34794000 |
| Wednesday, January 1, 2020 | 31931000 | 28304000 |
| Friday, January 1, 2021 | 44981000 | 56886000 |
| Saturday, January 1, 2022 | 54234000 | 100894000 |
| Sunday, January 1, 2023 | 63806000 | 159765000 |
Igniting the spark of knowledge
In the competitive world of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Viking Therapeutics, Inc. and Viridian Therapeutics, Inc. have demonstrated contrasting strategies over the past decade. From 2014 to 2023, Viking Therapeutics increased its R&D expenses by nearly 190%, reaching a peak in 2023. Meanwhile, Viridian Therapeutics exhibited a staggering growth of over 54,000% in the same period, underscoring its aggressive investment in R&D. Notably, in 2023, Viridian's R&D spending was approximately 2.5 times that of Viking. This strategic focus on R&D highlights the companies' dedication to advancing their therapeutic pipelines. As the biotech industry continues to evolve, these investments may well determine the future leaders in innovative treatments.
Novo Nordisk A/S vs Viridian Therapeutics, Inc.: Strategic Focus on R&D Spending
R&D Spending Showdown: Halozyme Therapeutics, Inc. vs Viridian Therapeutics, Inc.
Research and Development Investment: Blueprint Medicines Corporation vs Viridian Therapeutics, Inc.
R&D Spending Showdown: Alkermes plc vs Viridian Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Alpine Immune Sciences, Inc. and Viking Therapeutics, Inc.
Viking Therapeutics, Inc. or CRISPR Therapeutics AG: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Viking Therapeutics, Inc. vs HUTCHMED (China) Limited
Research and Development Expenses Breakdown: Viking Therapeutics, Inc. vs Xencor, Inc.
Analyzing R&D Budgets: Veracyte, Inc. vs Viridian Therapeutics, Inc.
Research and Development Expenses Breakdown: Arrowhead Pharmaceuticals, Inc. vs Viridian Therapeutics, Inc.
Analyzing R&D Budgets: Supernus Pharmaceuticals, Inc. vs Viridian Therapeutics, Inc.